New York City-based Memorial Sloan Kettering Cancer Center is collaborating with ALIGNMT AI to pilot a governance platform for responsible deployment of artificial intelligence in oncology.
ALIGNMT AI joined the Memorial Sloan Kettering Innovation Hub to support operationalization of the center’s internal AI lifecycle management framework. The pilot aims to integrate AI governance into Memorial Sloan Kettering’s production workflows, with a focus on real-time risk monitoring, according to an Oct. 1 news release from ALIGNMT AI.
The partnership is intended to offer a scalable model for AI oversight in healthcare as institutions face increasing regulatory and safety demands, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
